波音游戏源码-波音博彩公司评级_百家乐园天将_新全讯网3344111.c(中国)·官方网站

Greater Bay Biotechnology

 

Greater Bay Biotechnology focuses on developing innovative microneedles device for drug and cell delivery. Our cryomicroneedles (CMNs) is an innovative device which allows effective storage, transportation, and in situ delivery of living cells, biologics and drug. Applications include diabetes treatment, cell and dermatology therapy.

Greater Bay Biotechnology is founded by researchers from City University of Hong Kong and is supported by CityU HK Tech 300 Seed Fund and The Hong Kong Science and Technology Parks Corporation (HKSTP) IDEATION Programme. We received multiple accolades for our innovation.

We work in partnership with pharmaceutical companies to develop innovative, minimally invasive and safe drug and cell delivery solutions. This include delivering insulin using our CMNs as a minimally invasive treatment option for the 130 million diabetes patients in China. We also expand the application of microneedles technology in the delivery of other drug, cosmetic and cell formulations.

 

 

Team members

Mr Ng Chelon Colin* (Master, Dept. of Biomedical Sciences, CityU)
Dr Zheng Mengjia (Postdoc, Dept. of Biomedical Engineering, CityU)
Ms Zhang Yuyue (PhD, Dept. of Biomedical Engineering, CityU)
Ms Zhang Jitian (PhD, Dept. of Biomedical Sciences, CityU)

* Person-in-charge
(Info based on the team's application form)

Achievement(s)
  1. CityU HK Tech 300 Seed Fund (2021)
  2. The Hong Kong Science and Technology Parks Corporation (HKSTP) IDEATION Programme
  3. Second runner-up, Hong Kong Chapter of “Maker in China” SME Innovation and Entrepreneurship Global Contest 2021
  4. Silver Prize, The 7th China International College Students’ “Internet+” Innovation and Entrepreneurship Competition
  5. Second prize, The 4th "Beijing-Hong Kong Youth Innovation and Entrepreneur Cup" Entrepreneurship Competition
  6. Third Prize, 2022 Chengdu "Rongpiao Cup" High-level Talents Innovation and Entrepreneurship Competition (Shuangliu District and Guangdong-Hong Kong-Macao Greater Bay Area Competition)
  7. Third prize, 2021 “創匯香湘" Innovation and Entrepreneurship Competition
  8. Selected to be in the Ministry of Industry and Information Technology (MIIT) First "Light of Innovation" SME technological innovation outstanding achievement list  (the only selected enterprise in Hong Kong, Macao and Taiwan)
  9. Selected to be as The 4th Guangdong-Hong Kong-Macao Greater Bay Area Top 50 Innovative Biotechnology Enterprises

 


百家乐技巧心| 哪个百家乐最好| 凯发百家乐官网是否是程序控制| 太阳城娱乐总站| 大发888官网z46| 金矿百家乐官网的玩法技巧和规则 | 网络博彩qq群| 优惠搏百家乐官网的玩法技巧和规则| 德州扑克 下载| 网上百家乐官方网站| 百家乐官网的关键技巧| 百家乐官网群详解包杀| 太阳城会员| 百家乐如何打公式| 百家乐官网等投注网改单| 百家乐怎赌才赢钱| 陈巴尔虎旗| 百家乐娱乐城体验金| 太阳城百家乐官网娱乐开户| 大发888有赢钱的吗| 百家乐官网群html| 大发8888娱乐场| 百家乐娱乐城注册| 澳门百家乐官网必胜看路| 大发888 ber娱乐场下载| 百家乐太阳城真人游戏| 百家乐官网电脑上怎么赌| 大发888 赌博网站大全| 百家乐排名| 百家乐官网游戏什么时间容易出对| 姚记百家乐的玩法技巧和规则| 玩百家乐官网保时捷娱乐城| 大发888娱乐场下载zhidu| 百家乐永利赌场娱乐网规则| 安桌百家乐官网游戏百家乐官网 | 庄闲和| 全讯网777| 百家乐官网任你博娱乐场| 明升娱乐城开户| 澳门百家乐玩法心得技巧| 百家乐官网第三张规则|